Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

MedTech Acquisition Corporation (MTAC)

10.05   0 (0%) 11-28 09:30
Open: 10.05 Pre. Close: 10.05
High: 10.08 Low: 10.05
Volume: 5,155 Market Cap: 251(M)

Technical analysis

as of: 2022-11-28 10:20:29 AM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 11.77     One year: 13.75
Support: Support1: 10.01    Support2: 9.97
Resistance: Resistance1: 10.07    Resistance2: 11.77
Pivot: 10.02
Moving Average: MA(5): 10.04     MA(20): 10.02
MA(100): 9.93     MA(250): 9.88
MACD: MACD(12,26): 0     Signal(9): 0
Stochastic oscillator: %K(14,3): 52.3     %D(3): 64.9
RSI: RSI(14): 71.6
52-week: High: 10.21  Low: 8.98
Average Vol(K): 3-Month: 24 (K)  10-Days: 20 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ MTAC ] has closed below upper band by 9.6%. Bollinger Bands are 17.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 10.05 - 10.12 10.12 - 10.17
Low: 9.91 - 9.97 9.97 - 10.03
Close: 9.94 - 10.05 10.05 - 10.14

Company Description

MedTech Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the healthcare sector in the United States.. The company was incorporated in 2020 and is based in Greenwich, Connecticut.

Headline News

Sun, 27 Nov 2022
MedTech (MTAC) Terminates Memic Deal Ahead of Completion Vote|SPACInsider - SPACInsider

Mon, 21 Nov 2022
Form 425 MedTech Acquisition Corp Filed by: MedTech Acquisition Corp -

Mon, 21 Nov 2022
TriSalus Life Sciences Provides Updates on Pressure-Enabled Regional Immuno-Oncology™ (PERIO™) 01 and 02 Clinical Studies - Business Wire

Mon, 14 Nov 2022
Sarawak International Festival Music and Arts (SIFMA) - KuchingBorneo

Mon, 14 Nov 2022
MedTech Acquisition signs SPAC merger deal with TriSalus Life Sciences (NASDAQ:MTAC) - Seeking Alpha

Wed, 31 Aug 2022

Financial Analysis

Price to Book Value: Underperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Underperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Financial Services
Industry:  Shell Companies
Shares Out. 25 (M)
Shares Float 25 (M)
% Held by Insiders 0 (%)
% Held by Institutions 97.4 (%)
Shares Short 5 (K)
Shares Short P.Month 4 (K)

Stock Financials

EPS 0.28
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -0.38
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) 0
Return on Equity (ttm) 0
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth -64.6
Operating Cash Flow -2 (M)
Levered Free Cash Flow 0 (M)

Stock Valuations

PE Ratio 35.89
PEG Ratio 0
Price to Book value -27.17
Price to Sales 0
Price to Cash Flow -116.87

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.